Exodus Point Capital Management, LP Standard Biotools Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Standard Biotools Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 304,495 shares of LAB stock, worth $566,360. This represents 0.01% of its overall portfolio holdings.
Number of Shares
304,495Holding current value
$566,360% of portfolio
0.01%Shares
9 transactions
Others Institutions Holding LAB
# of Institutions
146Shares Held
265MCall Options Held
356KPut Options Held
400-
Casdin Capital, LLC New York, NY61.9MShares$115 Million13.55% of portfolio
-
Viking Global Investors LP58.7MShares$109 Million0.61% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny14.4MShares$26.7 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$24.3 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$24.2 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $146M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...